Try Alerts Free   |   Login

Cleveland Biolabs Financials and Smart Investor 13F Alerts

CBLI Sector: Health Care, Services-Commercial Physical And Biological Research

Data imported from SEC filings and provided as-is without any warranty. Check Cleveland Biolabs Inc filings before making any investment decision.

CBLI stock chart compared to Revenue:
Get email alerts for new filings: We will never share your email address. By submitting your email, you agree to our Terms of Service and Privacy Policy.

CBLI Income Statement

Revenue, Net:63255
Research and Development Expense:170007
Total Operating Expenses:655446
Operating Income:-592191
Income Taxes:0
Net Income (Loss) Attributable to Parent:-369838
Earnings Per Share, Diluted:-0.03
Earnings Per Share, Basic:-0.03
Weighted Average Number of Shares Outstanding, Basic:13016387
Weighted Average Number of Shares Outstanding, Diluted:11947364

CBLI Cash Flow

Depreciation, Depletion and Amortization:2848
Net Cash from Operations:-476411
Net Cash from Financing Activities:2783425
Net Cash from Investing Activities:null
Net Change in Cash and Cash Equivalents:2350499

CBLI Balance Sheet

Cash and Cash Equivalents:3800000
Short-Term Investments:357391
Accounts Receivable, Net:246552
Other Short-Term Assets:56751
Total Current Assets:4070004
Property, Plant and Equipment, Net:9233
Other Long-Term Assets:null
Total Assets:4079237
Accounts Payable:301618
Total Short-Term Liabilities:787335
Total Liabilities:787335